Voice of America - September 8, 2005
Lisa Bryant
Paris
African health ministers and development experts are gathering in Paris Thursday, for a two-day summit aimed at creating new momentum to fight malaria in Africa.
The World Bank estimates that $2 billion are needed, each year, to fully fight against malaria - a deadly but also extremely treatable disease. So far, only about half that amount is available to do the job.
Why is malaria lacking the kind of attention and dollars showered on other diseases, such as HIV/AIDS? Jean-Louis Sarbib, senior president for human development at the World Bank, has one answer.
"I think there has been a very sad story that malaria is essentially a disease of poor people," he said. "There hasn't been much voice and much pressure, especially outside of poor communities, outside of Africa, to raise the profile of this disease. "
But that is changing. Mr. Sarbib points to July's G8 summit in Scotland, gathering the leaders of industrialized nations. They made a commitment to tackle malaria as part of an overall goal to help Africa.
"Now the G8 has highlighted malaria; now that the numbers are very clear; now that the ministers of finance in many African countries are realizing malaria is actually reducing their growth - is exacting an enormous toll on the production of goods and services - then malaria is climbing back up on the top of the development agenda," he said.
Mr. Sarbib says the two-day summit in Paris is not aimed at getting specific funding commitments, but, rather, at building up a momentum to fight malaria-- with a hope that the dollars to help do so will follow. Experts are also expected to discuss ways to make available effective-but-expensive anti-malarial drugs which most Africans are unable to afford.
Malaria has long grown resistant to the drugs most Africans can afford. But there are also other, less costly malaria-fighting measures, which do not need to wait for new donor commitments. One of them: Making sure African families have insecticide-treated bed nets.
050908
VA050904
Copyright © 2005 - Voice of America. You are welcome to use any material that is published by voanews.com, or you may link to any of the web pages that Voice of America has published on the internet. There is no need to request further permission. Should you wish to establish a link to any VOA web pages, please send your request to pubaff@ibb.gov. We would appreciate that credit for any use of VOA material be given to voanews.com, Voice of America, or VOA, and we ask that you not abridge or edit any VOA material which you may use.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, the National Library of Medicine, Bridgestone Firestone Trust Fund, and donations from users like you. Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .